- Home
- Publications
- Publication Search
- Publication Details
Title
Progress in the genetics of ankylosing spondylitis
Authors
Keywords
-
Journal
Briefings in Functional Genomics
Volume 10, Issue 5, Pages 249-257
Publisher
Oxford University Press (OUP)
Online
2011-10-01
DOI
10.1093/bfgp/elr023
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A novel antagonist of the prostaglandin E2 EP4 receptor inhibits Th1 differentiation and Th17 expansion and is orally active in arthritis models
- (2010) Q Chen et al. BRITISH JOURNAL OF PHARMACOLOGY
- Contribution of functional KIR3DL1 to ankylosing spondylitis
- (2010) Ivan V Zvyagin et al. Cellular & Molecular Immunology
- Genome-wide association study of ankylosing spondylitis identifies non-MHC susceptibility loci
- (2010) John D Reveille et al. NATURE GENETICS
- A genome-wide association study identifies new psoriasis susceptibility loci and an interaction between HLA-C and ERAP1
- (2010) Amy Strange et al. NATURE GENETICS
- Signaling by intrathymic cytokines, not T cell antigen receptors, specifies CD8 lineage choice and promotes the differentiation of cytotoxic-lineage T cells
- (2010) Jung-Hyun Park et al. NATURE IMMUNOLOGY
- The chromosome 16q region associated with ankylosing spondylitis includes the candidate gene tumour necrosis factor receptor type 1-associated death domain (TRADD)
- (2009) J. J. Pointon et al. ANNALS OF THE RHEUMATIC DISEASES
- ARTS1 polymorphisms are associated with ankylosing spondylitis in Koreans
- (2009) C.-B. Choi et al. ANNALS OF THE RHEUMATIC DISEASES
- Association ofERAP1, but notIL23R, with ankylosing spondylitis in a Han Chinese population
- (2009) Stuart I. Davidson et al. ARTHRITIS AND RHEUMATISM
- Genetics and the pathogenesis of ankylosing spondylitis
- (2009) Matthew A Brown CURRENT OPINION IN RHEUMATOLOGY
- Comprehensive follow-up of the first genome-wide association study of multiple sclerosis identifies KIF21B and TMEM39A as susceptibility loci
- (2009) et al. HUMAN MOLECULAR GENETICS
- Effectiveness, Safety, and Predictors of Good Clinical Response in 1250 Patients Treated with Adalimumab for Active Ankylosing Spondylitis
- (2009) M. RUDWALEIT et al. JOURNAL OF RHEUMATOLOGY
- Association of ARTS1 Gene Polymorphisms with Ankylosing Spondylitis in the Hungarian Population: The rs27044 Variant Is Associated with HLA-B*2705 Subtype in Hungarian Patients with Ankylosing Spondylitis
- (2009) B. PAZAR et al. JOURNAL OF RHEUMATOLOGY
- Genome-wide association study identifies new multiple sclerosis susceptibility loci on chromosomes 12 and 20
- (2009) Melanie Bahlo et al. NATURE GENETICS
- Comprehensive Linkage and Association Analyses Identify Haplotype, Near to the TNFSF15 Gene, Significantly Associated with Spondyloarthritis
- (2009) Elena Zinovieva et al. PLoS Genetics
- The prevalence, clinical features and association of HLA-B27 in sacroiliitis associated with established Crohn’s disease
- (2008) T. R. ORCHARD et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Endoplasmic reticulum stress and the unfolded protein response are linked to synergistic IFN-β inductionvia X-box binding protein 1
- (2008) Judith A. Smith et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Analysis of 17 autoimmune disease-associated variants in type 1 diabetes identifies 6q23/TNFAIP3 as a susceptibility locus
- (2008) E Y M G Fung et al. GENES AND IMMUNITY
- Mesenchymal cell targeting by TNF as a common pathogenic principle in chronic inflammatory joint and intestinal diseases
- (2008) Maria Armaka et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Common variants at CD40 and other loci confer risk of rheumatoid arthritis
- (2008) Soumya Raychaudhuri et al. NATURE GENETICS
- Genome-wide association defines more than 30 distinct susceptibility loci for Crohn's disease
- (2008) Jeffrey C Barrett et al. NATURE GENETICS
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started